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ABSTRACT: Despite its growing popularity and use, bottom-up proteomics remains a complex analytical methodology. Its general
workflow consists of three main steps: sample preparation, liquid chromatography coupled to tandem mass spectrometry (LC−MS/
MS), and computational data analysis. Quality assessment of the different steps and components of this workflow is instrumental to
identify technical flaws and avoid loss of precious measurement time and sample material. However, assessment of the extent of
sample losses along with the sample preparation protocol, in particular, after proteolytic digestion, is not yet routinely implemented
because of the lack of an accurate and straightforward method to quantify peptides. Here, we report on the use of a microfluidic UV/
visible spectrophotometer to quantify MS-ready peptides directly in the MS-loading solvent, consuming only 2 μL of sample. We
compared the performance of the microfluidic spectrophotometer with a standard device and determined the optimal sample
amount for LC−MS/MS analysis on a Q Exactive HF mass spectrometer using a dilution series of a commercial K562 cell digest. A
careful evaluation of selected LC and MS parameters allowed us to define 3 μg as an optimal peptide amount to be injected into this
particular LC−MS/MS system. Finally, using tryptic digests from human HEK293T cells and showing that injecting equal peptide
amounts, rather than approximate ones, result in less variable LC−MS/MS and protein quantification data. The obtained quality
improvement together with easy implementation of the approach makes it possible to routinely quantify MS-ready peptides as a next
step in daily proteomics quality control.
■ INTRODUCTION
Mass spectrometry (MS)-based proteomics is a key technology
in modern life sciences, with a wide scope of applications for
protein research. Due to technological advances in liquid
chromatography (LC) and MS instrumentation, current LC−
MS/MS systems perform at high sensitivity, resolution, and
speed.1−4 These improvements, coupled to robust bioinfor-
matic pipelines, now allow routine in-depth proteome
measurements at high confidence, explaining the success of
the major proteomics applications today: quantitative measure-
ments of proteomes by so-called shotgun proteomics,
identification of protein interaction partners by affinity
purification MS (AP-MS), and mapping of some of the most
common post-translational modification (PTM) sites.
LC−MS/MS systems are inherently prone to fluctuations in
performance. Whether an ion source that gets transiently
unstable in the course of an analytical run, a mass analyzer with
a drift in accuracy, or a chromatographic column whose
stationary phase progressively deteriorates, the different
components of an LC−MS/MS system vary during the
operation time.5 Therefore, continuous monitoring is required
to diagnose technical flaws and schedule maintenance
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interventions. For a very long time, however, guidelines and
standardized methods to assess the quality of MS-based
proteomics data were lacking. Over the last decade, great
progress has been made in proteomics quality control. On the
one hand, various reference sample formulations have been
designed and are now commercialized as standards to carry out
quality control (QC) analysis.5,6 On the other hand, a number
of metrics to assess LC−MS/MS performance have been
developed,7,8 in particular, for standard workflows of bottom-
up data-dependent analysis. Examples of QC metrics that
inform about the liquid chromatography step are full-width at
half-maximum (FWHM) of the eluting peptide peak and
retention time drifts of eluting peptides, which monitor the
integrity of the chromatographic column and the applied
gradient. In turn, mass spectrometer QC can be done through
examination of mass accuracy, dynamic range, and ion
injection time. Importantly, various software tools for MS-
based proteomics QC have been created,9 which allow
extraction and visualization of QC metrics from analytical
runs performed on standard samples. One such example is a
cloud-based quality control system QCloud that allows
following instrument performance over time on a user-friendly
web interface.10
Of utmost importance for the success of a proteomic
experiment is the QC assessment at the sample preparation
level, where the major sources of variation arise from (1)
artificial and thus unwanted in vitro protein/peptide
modifications, (2) incomplete protein digestion, (3) protein
contamination introduced by users or present in reagents, and
(4) sample losses during sample transfer, enrichment steps,
elution, and reconstitution. While the extent at which the first
three types of variation compromise the quality of an analytical
run can be quantified (provided that the correct identification
search settings are used), no standardized QC procedures exist
that account for analyte losses after proteolytic digestion.
Indeed, while the extracted amount of protein material from
cell or tissue samples is typically determined by standard assays
immediately upon lysis and/or protein extraction, or prior to
digestion (Figure 1), no such established quantification
procedures exist at the peptide level. An exception would be
the bicinchoninic acid (BCA) method using a peptide digest
sample standard, but its dependence on calibration and the
consumption of large sample volumes make it lengthy and
costly. Of particular note, even when additional modifications,
enrichment steps, or cleaning procedures take place after
digestion, which will inevitably introduce additional sample
losses and variability, peptide quantification before the actual
LC−MS/MS analysis is generally not performed.
LC−MS/MS runs carried out with insufficient amounts of
peptides result in ion signals below the detection limit of the
mass spectrometer, leading to low(er) numbers of peptide and
protein identifications. In this respect, low signal-to-noise
ratios of peptide signals also reduce the reliability of peptide
quantification, as peak integration is more difficult for such low
signals. Although analysis can be repeated by injecting more
adequate sample amounts, this increases the overall analysis
time and associated costs and is not always possible for low-
quantity or low-volume samples. Equally troublesome is the
injection of excessive amounts of peptide material, termed
column overloading. Such column saturation leads to peak
tailing and retention time shifts,11−15 leading to poorer peptide
separation and higher ionization competition, also reducing the
number of identified and quantified peptides.16 In some cases,
this saturation can even lead to the obstruction of the column,
which causes backpressure build-up, in turn increasing the
variability between repeated analyses of similar samples.
Efforts to standardize procedures and minimize sample
losses during sample preparation led to the development of
simplified uniform protocols, including protocols in which all
predigestion steps, such as lysis, protein reduction, and
alkylation, are performed in a single volume.17−19 Solid-phase
extraction (SPE) to purify and concentrate peptides has also
become a common practice at the end of the sample
preparation protocol. Furthermore, automated sample prep-
aration workflows20,21 or robotized systems start to become
available, which allow accurate liquid handling, temperature
control, and precise timing of processing steps.22,23 Some of
these methods can be performed in miniaturized settings,
which are advantageous when working with clinical or other
low-abundance samples where analyte amounts are scarce.22,24
Even when optimized sample preparation protocols are in
place, straightforward QC assessment at the peptide level
would be highly desirable for monitoring sample losses, leading
to injecting optimal peptide amounts for LC−MS/MS analysis.
For such a procedure to be aligned with a miniaturized, high-
throughput mass spectrometry workflow, it should allow (1)
batchwise processing, (2) low sample consumption, and (3)
execution just before LC−MS/MS analysis in the loading
solvent used. Here, we present a procedure that complies with
these requirements, based on peptide quantification directly in
MS-loading buffer, in a microvolume, microfluidic, UV−visible
spectrophotomer that can process several samples simulta-
neously. Using this procedure, we determined the optimal
amount of peptides to be injected for shotgun measurements
on our LC−MS/MS setup. Finally, we demonstrated that the
application of this procedure for the control of sample loading
improves LC−MS/MS and protein quantitation reproduci-
bility.
Figure 1. Schematic outline of the sample preparation and
quantification steps in a generic bottom-up proteomics experiment.
Peptide concentration is usually estimated based on protein
quantification before proteolytic digestion (dark gray), but standard
methods for performing this quantification at the peptide level, right
before LC−MS/MS (red), would be highly desirable. Optional steps
of the protocol are written in gray.
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■ RESULTS AND DISCUSSION
The introduction of a peptide purification step prior to LC−
MS/MS analysis24 in routine in proteomics laboratories
opened an opportunity to accurately determine peptide
concentrations. Such a peptide purification step, typically
based on solid-phase extraction (SPE), removes buffer
components (like chaotropes, certain detergents, reducing/
alkylating reagents, and trypsin) that interfere with LC−MS/
MS analysis. As these components often absorb UV light, for a
long time, they prevented routine, fast, and accurate peptide
quantification, often leading to the analysis of suboptimal
peptide amounts by LC−MS/MS. The high purity of peptides
obtained after SPE led us to explore the possibility to quantify
MS-ready peptide samples using a new-generation UV−visible
spectrophotometer.
Simple Application for Accurate Quantification of
MS-Ready Peptide Samples. The Lunatic instrument, from
Unchained Labs, is a microfluidic spectrophotometer that
performs DNA, RNA, protein, and peptide quantifications in
batch, consuming only 2 μL of sample. Determination of
peptide concentrations happens accurately by a proprietary
software application that, from an acquired UV−visible
absorbance spectrum, discriminates the signal coming from
the UV-light-absorbing amino acids from those of usual
contaminants (e.g., nucleic acids, cofactors). The “MS-peptide
Quant” application quantifies peptides by taking into account
the 280 nm molar extinction coefficient and the molecular
weight of the average peptide species in a sample.
The ability to quantify complex peptide mixtures was
verified using dilution series of commercial protein digests
from yeast, ranging in concentration between 10 ng/μL and 1
μg/μL, based on the theoretical peptide quantity as reported
by the vendor. Comparison between the theoretical concen-
tration values and the measured ones in four independent
replicate dilutions showed a high linear correlation (R2 > 0.98)
and a slope very close to 1 (t-test p-value = 0.19),
demonstrating the instrument’s high accuracy (Figure 2).
Meanwhile, it was noticed that peptide solutions with
concentrations below 50 ng/μL gave absorbance measure-
ments lower than 0.03, the lower absorbance limit at which the
analyte concentration can be accurately assessed according to
the instrument specifications. Therefore, it was concluded that
solutions of peptides with concentrations between 50 ng/μL
and 1 μg/μL are within the dynamic range of the instrument
and can thus be accurately measured. This concentration range
is well suited for MS-ready samples, for which LC−MS/MS
experiments typically consume peptide quantities between 100
ng and 5 μg, contained in a volume of a few microliters.
We next compared peptide mixture quantification on our
microfluidic device with quantification on a NanoDrop, a
reference instrument among the class of microvolume
spectrophotometers, which has also been used for measure-
ments of MS-ready peptide samples.25−27 In particular, we
performed A280 measurements of five samples of HEK293
tryptic digests and compared across-instrument mean and
coefficients of variation (CV) values. This analysis showed that
quantification estimates differ slightly between instruments,
with those from Lunatic always laying below those of
NanoDrop (8−19% lower means across the five samples,
Mann−Whitney U test p-value < 0.05) (Figure S2).
Furthermore, in terms of precision, this was visibly higher in
Lunatic relative to NanoDrop (55−81% lower CV across the
five samples).
In summary, together with its accuracy for the measurement
of peptide solutions at commonly used concentration ranges,
peptide quantitation with the Lunatic instrument presents a
unique set of characteristics that make it particularly attractive
over other quantification methods for MS-ready bottom-up
proteomics samples (e.g., Bradford, Lowry, BCA, Pierce 660
nm, tryptophan fluorescence,28 and other A280 methods). It is
a quick and easy method that can be performed in batch. It
only implies a very low, 2 μL, sample consumption. It is based
on UV light absorbance at 280 nm, an intrinsic property of
aromatic amino acids, thus requiring no calibration curve,
unlike colorimetric reaction-based assays like Bradford or BCA.
Finally, with this instrument, it is possible to reach a higher
level of precision than with other reference spectrophotom-
eters also performing A280-based peptide quantification.
Determination of an Optimal Peptide Amount for
LC−MS/MS Analysis. The ideal peptide amount to use for
LC−MS/MS to have a maximum throughput and identi-
fication rate, while keeping a good analyte separation, will
largely depend on the characteristics of the LC−MS/MS
system, namely, on its chromatographic column loading
capacity. If the exact sample concentration would be known,
it would be possible to always work with optimal sample
amounts and thus consistently get high-quality LC−MS/MS
runs.
Therefore, taking advantage of peptide quantification by the
microfluidic spectrophotometer, we set out to determine the
most suitable sample loading for an LC−MS/MS setup
routinely used in our laboratory: a 40 cm LC column packed
Figure 2. Dynamic quantification range of the microfluidic
spectrophotometer for complex peptide mixtures. Yeast peptide
digest solutions with concentrations ranging from 10 ng/μL to 1.0
μg/μL (black dots) can be accurately measured, as shown by a strong
correlation between the theoretical and measured peptide concen-
tration values. Below 50 ng/μL (red dots), peptide measurements are
no longer reliable, as absorbance values reach the lower limit of
detection of the spectrophotometer. Dots represent measurements of
four independent replicate dilutions.
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in the needle with 1.9 μm C18 beads coupled to a Q Exactive
HF mass spectrometer.
Starting from a commercial tryptic digest of a K562 cell
lysate, we prepared 10 different samples, from which 5 μL,
containing peptide amounts ranging from 0.06 to 12 μg, was
injected for LC−MS/MS analysis using a 2.5 h gradient. The
experiment was repeated to generate data for two independent
series of replicates analyzed on two different LC columns
(Figures 3 and S3).
All peptide concentration measurements were lower than
predicted (Figure 3a). Likely, these deviations arose mostly
from peptide losses during peptide resuspension of the K562
digest, as additional losses during the preparation of serially
diluted samples were minor (R2 > 0.99 for the comparison of
theoretical vs measured sample concentrations). We also
noticed that peptide quantification of #Dilution 1 and 2,
having theoretical concentrations of 0.013 and 0.025 μg/μL,
respectively, returned negative values. These clearly inaccurate
Figure 3. Quality control metrics from LC−MS/MS analysis of 10 different amounts of a trypsin-digested K562 cell extract. (a) Theoretical and
measured peptide amounts for two independent experiments. In both experiments, all measured values were lower than predicted, pointing to
peptide losses during sample solution preparation. (b) Bar plots indicating the numbers of identified peptide and proteins per analytical run. Colors
represent the results of two replicate series analyzed on two different LC columns. (c) Representative heatmap visualizing the intensities of
quantified proteins in each of the 10 analytical runs measured using LC column 1. Missing values are shown in gray. Based on numbers of identified
and quantified proteins a rather broad window ranging from 1.49 to 5.20 μg of peptides was found as an optimal injection amount. (d) Scatter plots
of average MS2 ion injection time, median peak area, and median signal-to-noise ratio (S/N) of identified peptides in each analytical run. (e)
Scatter plots of the median peak area of hydrophilic, intermediate hydrophobic, and hydrophobic identified peptides. For both replicate series, from
around 2−3 μg, peak areas decline steeply for hydrophilic peptides, while they go up progressively for hydrophobic peptides, two types of peptide
classes having a lower and higher affinity for the used precolumn, respectively. Colors represent the results of two replicate series analyzed on two
different LC columns. Loss curve fitting was used to generate the connecting lines. Based on the loss of hydrophilic peptides, 3 μg was defined as an
optimal peptide injection amount for this particular LC−MS/MS setup (dashed lines).
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measurements were performed below the limit of detection of
the spectrophotometer.
To find an optimal peptide amount to inject into our LC−
MS/MS setup, we evaluated the rates of identified and
quantified proteins. To this end, the LC−MS/MS data were
searched with MaxQuant29 and identified proteins were
quantified by the MaxLFQ algorithm30 (Figures 3b,c and S3
and Table S1). The number of identified peptides reached a
maximum between 1.49 and 3.28 μg and showed a marked
decrease for higher peptide amounts (18−20% reduction in
the number of identified peptides for the 10.99 μg samples),
likely due to column overloading. In turn, identified and
quantified protein numbers increased with the injected peptide
amount until 3.28−5.20 μg, above which they started to level
off and the same trend was seen for individual proteins (Figure
S3). Based on these numbers, a rather broad window ranging
from approximately 1.49−5.20 μg of peptides was found as an
optimal peptide injection amount for our LC−MS/MS setup.
In an attempt to further narrow down this window, we
evaluated selected LC and MS parameters. The efficient time
consumption of a mass spectrometer is, among other things,
reflected by the ion injection time. The closer to ideal the
amount of material presented to the mass spectrometer is, the
lower the injection time will be. Figure 3d (left panel) shows
that MS2 ion injection time reached an optimal minimum
around an average amount of 3.28 μg of injected peptides. We
also assessed the two LC parameters signal-to-noise (S/N)
ratio of chromatographic peaks and peak areas. Figure 3d
(right panel) shows that the average S/N ratio increased with
increasing peptide amounts and again leveled off at an average
sample amount of about 3.28 μg. Analysis of the median peak
area of all identified peptides showed a maximum between 5.20
and 7.08 μg for the two replicate experiments (Figure 3d,
middle). When overloading a reversed-phase C18 column, one
expects peak tailing, with a concomitant increase of the average
peak area due to repulsion effects of same-charge ions.13−15
The observed leveling off and even decrease in the peak area at
higher loads though contradicted this expectation. To explore
this further, we split peptides according to their retention time
interval in three parts: early eluting peptides (hydrophilic, n =
126), late eluting peptides (hydrophobic, n = 178), and the
ones eluting in between (mid eluting/intermediate hydro-
phobic peptides, n = 2304) (Figure S1). Such partitioning
procedure revealed that the registered decrease in peak areas
was due to a steep decline of hydrophilic peptides peak areas
(Figure 3e) starting from 2−3 μg of sample due to the use of a
trapping column in our LC−MS/MS setup, whose capacity did
not allow retention of the most hydrophilic peptides for higher
sample amounts, leading to this trend for hydrophilic peptides
loss.
The disadvantage of losing hydrophilic peptides does not
overrule the advantages of using a trapping column though if
void volumes are avoided.31 Therefore, based on the loss of
hydrophilic peptides for amounts above 2.86 and 2.63 μg for
replicate series 1 and 2, respectively (peptide amounts that
correspond to the peak maxima in the hydrophilic peptides
peak area plot), together with the stabilization of the other
parameters also around these sample amounts, we now
routinely use 3 μg of peptides as an optimal injection amount
on this particular LC−MS/MS setup.
By running a series of LC−MS/MS analysis, covering a
range of known peptide sample amounts, and performing a
follow-up evaluation of the numbers of identified and
quantified features, as well as of a few LC and MS parameters,
we were able to identify 3 μg as an optimal amount of injected
peptides for our LC−MS/MS setup. This procedure could be
applied to any other system and as such be of great use in
proteomics laboratories. Indeed, knowledge about the most
adequate sample amounts to use is currently not known for
most systems. As a workaround to deal with this lack of
information, it is common to either inject different
concentrations of the same sample or else to perform short
off-line analytical runs to fine-tune sample loading for a given
sample.32 However, these strategies are time- and cost-
Figure 4. Comparison of LC−MS/MS and protein quantification reproducibility for two sets of analytical runs on trypsin-digested Hek293T cell
extracts. (a) Plots of the average MS2 injection time, median peak area, and median signal-to-noise ratio values are shown for the identified
peptides in each of five replicates from the corrected and “noncorrected” groups of samples. For each data point, the exact injected peptide amount
based on quantification on the microfluidic spectrophotometer is shown on the right. Vertical bars represent the mean ± standard deviation. (b)
Density plots and boxplots showing the distribution of the coefficients of variation (CV) of raw intensities (left) and (normalized) maxLFQ
intensities (right) for all proteins quantified in the ten analytical runs (n = 2677). For both raw and normalized protein intensities, a shift to higher
CV values was found for the noncorrected samples (Mann−Whitney U test p-value < 2.2 × 10−16 for the shift in both raw and normalized
distributions).
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ineffective and often consume higher amounts of precious
sample material than the simple UV-based procedure described
here.
Control over Peptide Amount Injections Effectively
Stabilizes LC−MS/MS and Protein Quantitation Repro-
ducibility. During sample preparation, it is common to make
the protein amounts for all samples of a batch even before
proceeding to the digestion step. This will generate very
equivalent MS samples that can then be injected for LC−MS/
MS using equal volumes. We decided to evaluate whether, in
comparison to that approach, performing peptide quantifica-
tion prior to MS and concomitantly adjusting injection
volumes to account for small differences in samples
concentrations would have an impact on the reproducibility
of LC−MS/MS and, in particular, of quantitation data.
To this end, we analyzed five tryptic digests of HEK293
cells, prepared in parallel starting from five different cell pellets.
On the first set of analytical runs, we corrected for the peptide
amounts loaded based on measured sample concentration,
having injected exactly 3.0 μg of peptide mixture for all five
replicates. In contrast, on the second set of runs of the same
samples, we injected a fixed volume, corresponding to the
average used for the first experiment. After calculating the
peptide loadings for this second experiment, we realized there
was a difference of 1 μg between the lowest and highest
concentrations of the sample (2.5 and 3.55 μg, respectively).
These differences are quite substantial and show the
importance of accurate peptide quantitation of MS-ready
samples. Even with the automation of sample preparation,
which should alleviate heterogeneity between samples, peptide
quantitation could always be kept as a quality check step.
For both sets, the previously used MS and LC parameters
were examined (Figure 4a). Strikingly, while all MS injection
time, peak area, and S/N noise ratio values were close to each
other in the experiment with the “corrected” sample amounts,
these showed a much higher spread in the second experiment
where each analytical run had a different sample amount.
Indeed, the standard deviation for the MS2 injection time,
peak area, and S/N ratio had a tenfold, threefold, and twofold
increase, respectively, for the “noncorrected” experiment
relative to the corrected experiment (Figure 4a).
Finally, we checked whether this higher analytical reprodu-
cibility also resulted in a more precise protein quantification.
To this end, we looked at the distribution of the coefficients of
variation (CV) of raw protein intensity values from corrected
replicates versus those from noncorrected replicates. In
addition, we compared the CV distributions for label-free
quantitation (LFQ) protein intensity values obtained after
normalization by the MaxLFQ algorithm. As expected, CV
values for the non-normalized intensities were significantly
lower for the corrected experiment (Figure 4b, Mann−
Whitney U test p-value < 2.2 × 10−16). However, a shift
toward lower CV values was also observed for the normalized
LFQ intensities of the corrected experiment (Mann−Whitney
U test p-value < 2.2 × 10−16), indicating that computational
normalization cannot fully compensate for differences in
injection amounts. Such a reduction in the dispersion of
protein quantification estimates can potentially improve the
sensitivity for detecting peptide and protein regulation.
Together, these data show that working consistently with
equal peptide amounts results in increased reproducibility
LC−MS/MS and protein quantification data, even in
combination with the normalization of protein intensities
during data analysis.
■ CONCLUSIONS
In the present work, we describe a simple procedure to
quantify MS-ready peptides using a microfluidic UV−visible
spectrophotometer. This instrument, with its integrated
peptide quantification software application, constitutes an
accurate and easy-to-use device for the implementation of
peptide quantification in proteomics laboratories and facilities.
Through careful control of the injected peptide amount on a
commonly used LC−MS/MS setup, we show how this
procedure can provide a constant quality boost to MS-based
proteome analyses. The application of this methodology on a
routine basis can drastically reduce time and sample losses by
avoiding reruns after the injection of suboptimal peptide
amounts.
■ METHODS
Sample Preparation. HEK293 cells (5 × 5 × 106) were
harvested, washed 3 times in phosphate-buffered saline (PBS),
and resuspended in lysis buffer (8 M urea; 20 mM HEPES, pH
8.0). Samples were sonicated by three pulses of 15 s,
interspaced by 1 min pauses on ice, at an intensity output of
15 W, and centrifuged for 15 min at 20 000g at room
temperature to remove insoluble components. The protein
concentration in the supernatants of each sample was
measured using a Bradford assay (Bio-Rad), and equal protein
amounts (500 μg each) were used for further analysis. Proteins
were reduced with 5 mM dithiothreitol (DTT) (Sigma-
Aldrich) for 30 min at 55 °C. Alkylation was performed by the
addition of 10 mM iodoacetamide (Sigma-Aldrich) for 15 min
at room temperature in the dark. The samples were diluted
with 20 mM N-(2-hydroxyethyl)piperazine-N′-ethanesulfonic
acid (HEPES), pH 8.0, to a urea concentration of 4 M, and
proteins were pre-digested with 5 μg of endoLysC (Wako,
129−02541) (1/100, w/w) for 4 h at 37 °C. All samples were
further diluted with 20 mM HEPES, pH 8.0, to a final urea
concentration of 2 M, and proteins were digested with 5 μg of
trypsin (V5111, Promega) (1/100, w/w) overnight at 37 °C.
Peptides were then purified on a SampliQ SPE C18 cartridge
(Agilent), vacuum-dried, and kept at −20 °C until further use.
Peptide Concentration Measurements. Quantification
of peptide mixtures was based on the UV absorbance of
aromatic amino acids at 280 nm (A280), on the following
spectrophotometer models: a Lunatic microfluidic device
(Unchained Labs) and NanoDrop ND-1000 (Thermo Fisher
Scientific). In the case of Lunatic, peptide concentrations were
determined by the instrument’s MS-peptide Quant tool, while
the “A280” application was used with NanoDrop, with the
sample type option set to “1 Abs = 1 mg/mL”.
Linear Dynamic Range Determination. The linear
dynamic range for measurement of complex peptide mixtures
on the microfluidic spectrophotometer was determined on a
group of eight solutions prepared from a 1.0 μg/μL stock of a
commercial yeast protein digest (Promega, V7461), dissolved
in loading solvent (0.1% trifluoroacetyl (TFA) in acetonitrile/
water, 2:98 (v/v)). Measurements of solutions in the 1.0 μg/
μL to 10 ng/μL concentration range (used concentrations
were 0.010, 0.025, 0.050, 0.100, 0.250, 0.500, 0.750, and 1.000
μg/μL) were done in quadruplicate, from four yeast protein
digest vials, and at least two readouts per solution were taken.
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Comparison of Peptide Quantification in Distinct
Microvolume Spectrophotometers. Quantification of
peptide mixtures in the two microvolume spectrophotometers
was carried out on five samples of HEK293 tryptic digest (n =
10 repeated measurements each sample). Sample means and
coefficients of variation (CV) were compared.
Assessment of Optimal Loading Amount. A commer-
cially available K562 cell digest (Promega, V6951) was used to
create a twofold dilution series ranging from 0.013 to 2.4 μg/
μL. Peptide amounts ranging from 0.06 μg up to 12 μg were
loaded on an LC−MS/MS system. In parallel, the actual
sample concentration values were assessed with the MS-
peptide Quant method (see Figure 3a). The same experiment
was repeated using a new K562 cell vial to prepare the dilution
series and a different analytical column.
Assessment of LC−MS/MS Analysis Quality under
Controlled Sample Loading Conditions. Five HEK293
protein digest samples were resuspended in 30 μL of MS-
loading solvent (0.1% TFA in acetonitrile/water, 2:98 (v/v))
and measured with MS-peptide Quant. Two sets of LC−MS/
MS analytical runs followed. In the first one, 3.0 μg of peptide
mixture from each sample was loaded onto the LC−MS/MS
system, while in the second one, the same sample volume was
used for all five injections, resulting in peptide amounts ranging
from 2.50 to 3.55 μg (detailed in the Results section).
LC−MS/MS Analysis. From each sample, 5 μL was
introduced into an LC−MS/MS system through an Ultimate
3000 RSLC nano LC (Thermo Fisher Scientific, Bremen,
Germany) in-line connected to a Q Exactive HF mass
spectrometer (Thermo Fisher Scientific). The sample mixture
was first loaded on a trapping column (made in-house, 100 μm
internal diameter (I.D.) × 20 mm, 5 μm beads C18 Reprosil-
HD, Dr. Maisch, Ammerbuch-Entringen, Germany). After
flushing from the trapping column, the sample was loaded on
an analytical column (made in-house, 75 μm I.D. × 400 mm,
1.9 μm beads C18 Reprosil-HD, Dr. Maisch) packed in the
needle (pulled in-house). Peptides were loaded with the
loading solvent (0.1% TFA in acetonitrile/water, 2:98 (v/v))
and eluted with a nonlinear 150 min gradient of 2−56%
solvent B (0.1% formic acid in water/acetonitrile, 20:80 (v/v))
at a flow rate of 250 nL/min. This was followed by a 15 min
wash reaching 99% solvent B and re-equilibration with solvent
A (0.1% formic acid). The column temperature was kept
constant at 50 °C (CoControl 3.3.05, Sonation).
The mass spectrometer was operated in data-dependent,
positive ionization mode, automatically switching between MS
and MS/MS acquisition for the 16 most abundant peaks in a
given MS spectrum. The source voltage was set to 3.0 kV, and
the capillary temperature was 250 °C. Full-scan MS spectra
(375−1500 m/z, AGC target 3 × 106 ions, maximum ion
injection time of 45 ms) were acquired at a resolution of
60 000 (at 200 m/z) in the orbitrap analyzer, followed by up to
16 tandem MS scans (resolution 15 000 at 200 m/z) of the
most intense ions fulfilling predefined selection criteria (AGC
target, 1 ×105 ions; maximum ion injection time, 60 ms;
isolation window, 1.5 m/z; fixed first mass, 145 m/z; spectrum
data type, centroid; underfill ratio, 2%; intensity threshold, 1.3
× 104; exclusion of unassigned, singly, and >7 charged
precursors; peptide match preferred; exclude isotopes on;
and dynamic exclusion time, 12 s). The higher collisional
dissociation (HCD) collision energy was set to 28% of the
normalized collision energy and the polydimethylcyclosiloxane
background ion at 445.12002 Da was used for internal
calibration (lock mass).
Data Analysis. Data analysis was performed with
MaxQuant software (version 1.6.1.0).29 The Andromeda
search engine was used with default settings, including PSM,
peptide, and protein false discovery rate set at 1% and match
between runs disabled. Spectra were searched against the
Un iP ro t r e f e r ence p ro t eome re l e a s e 2018_01
(UP000005640_9606, containing 21007 human protein
entries) with a mass tolerance for precursor and fragment
ions of 4.5 and 20 ppm, respectively. The oxidation of
methionine residues and acetylation of protein N-termini were
defined as variable modifications, while carbamidomethylation
of cysteine residues was set as a fixed modification. Proteins
with at least one unique or razor peptide were retained and
then quantified by the MaxLFQ algorithm integrated into the
MaxQuant software.30 A minimum ratio count of two unique
or razor peptides was required for quantification. Further data
analysis was performed with the Perseus software (version
1.6.1.3) after loading the protein groups file from MaxQuant.
The number of protein identifications was given by the
number of protein groups obtained after filtering out protein
groups only identified by site, reverse database hits, and
potential contaminants. The number of peptide identifications
was obtained after the exclusion of reverse database hits and
potential contaminants. Quantified proteins were the subset of
identified proteins with positive LFQ intensities. Heat maps
were prepared from matrices of log 2-transformed LFQ protein
expression values, after filtering for at least three valid values
over all samples. Proteins were displayed according to the
order of groups defined by hierarchical clustering using
Euclidean distances and average linkage settings.
The chromatographic parameters signal-to-noise (S/N)
ratio and peak area were obtained using the moFF algorithm,33
executed on each analytical run. Peak areas were approximated
by the area of a triangle of base equal to the peak width (in
minutes) and height given by the peak’s apex intensity. The
MS2 injection time was retrieved from MaxQuant’s MS/MS
scans table. This analysis was done on peptide-to-spectrum
matches from features detected in every analytical run from
each experiment. Peptides were partitioned according to
hydrophobicity by the following way: hydrophilic peptides
were those eluting until 50 min of the LC gradient (1.6−12.3%
acetonitrile), intermediate hydrophobic peptides were eluted
between 50 and 110 min (12.3−26.6% acetonitrile), and
hydrophobic peptides were eluted after 110 min (26.6−79.2%
acetonitrile) (Figure S1).
The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium (http://
proteomecentral.proteomexchange.org) via the PRIDE partner
repository with the identifier 10.6019/PD014524.
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protein quantification with increasing sample loadings:
(a) heatmap visualizing the intensities of quantified
proteins in each of the 10 analytical runs measured using
LC column 2 (missing values are shown in gray) and (b)
association between protein signals and peptide sample
amount; and Table S1, numbers of identified and
quantified peptide and protein groups for the two
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